Check out our most popular compounded medications! Get Started
Sucralfate 5%/Lidocaine HCl 0.6%/Nystatin 30,000 Units/ml/Diphenhydramine HCl 0.05%/Hydrocortisone 0.05% Compound Oral Suspension is a liquid medication, where all ingredients are uniformly dispersed. This compounded formulation is used for the treatment of conditions such as Gastroesophageal Reflux Disease, Oral Thrush, Stomatitis, Aphthous Ulcers, and Oral Lichen Planus.
Licensed to fill prescriptions for patients in RI, MA, CT, NJ, NH, FL, ME and PA. New York patients are served on a limited basis while nonresident registration is pending.
Bayview Pharmacy is pleased to present a specially compounded oral suspension that incorporates Sucralfate 5%, Lidocaine HCl 0.6%, Nystatin 30,000 Units/ml, Diphenhydramine HCl 0.05%, and Hydrocortisone 0.05%. This unique blend of medications is formulated to address a range of conditions, including but not limited to gastroesophageal reflux disease, ulcers, and oral candidiasis.
Sucralfate is an anti-ulcer medication that functions by creating a protective barrier over the ulcer, aiding in pain reduction and promoting healing. Lidocaine HCl is a local anesthetic that alleviates pain and discomfort associated with ulcers. Diphenhydramine HCl is an antihistamine that helps to mitigate inflammation and itching associated with oral candidiasis. Hydrocortisone is a corticosteroid that aids in reducing inflammation and itching associated with oral candidiasis.
This combination of medications is designed to provide symptomatic relief from gastroesophageal reflux disease, ulcers, and oral candidiasis. It is crucial to understand that this medication should only be used as directed by a healthcare provider. If you have any queries about this formulation or how it can assist in treating your condition, please do not hesitate to contact us at Bayview Pharmacy.
The oral suspension is a liquid dosage form in which the ingredients are uniformly dispersed throughout a liquid medium. This ensures a homogeneous mixture for administration, allowing for consistent dosing and optimal therapeutic effect. The liquid form also offers ease of swallowing, making it a suitable option for patients who may have difficulty swallowing solid dosage forms.
This compounded formulation of Sucralfate 5%/Lidocaine HCl 0.6%/Nystatin 30,000 Units/ml/Diphenhydramine HCl 0.05%/Hydrocortisone 0.05% Compound Oral Suspension is a liquid dosage form that provides a homogeneous mixture for administration. It is primarily used in the treatment of various oral conditions such as oral mucositis, aphthous ulcers, and oral candidiasis.
Patients with known hypersensitivity to any of the components of this formulation should refrain from using it. Special caution is advised for patients with a history of gastrointestinal obstruction, as the sucralfate component may exacerbate the condition.
It is crucial to be aware of potential drug interactions when using this formulation. Lidocaine HCl and Diphenhydramine HCl may interact with medications that affect the central nervous system, including benzodiazepines, barbiturates, and tricyclic antidepressants. Hydrocortisone may interact with medications that affect the endocrine system, such as estrogens, progestins, and androgens.
Adverse reactions associated with this formulation may include nausea, vomiting, and diarrhea. Allergic reactions such as rash, hives, and itching may also occur. If you experience any of these symptoms, it is recommended to seek medical attention immediately.
If you have any questions or concerns about this formulation, potential interactions, or adverse reactions, please do not hesitate to reach out for further information.
This compounded oral suspension formulation contains Sucralfate 5%, Lidocaine HCl 0.6%, Nystatin 30,000 Units/ml, Diphenhydramine HCl 0.05%, and Hydrocortisone 0.05%. It is specifically designed to address a range of conditions such as oral ulcers, mouth sores, and other inflammatory conditions affecting the mouth and throat. The unique combination of ingredients works synergistically to alleviate inflammation, manage pain, and foster healing.
Sucralfate, an anti-ulcer medication, functions by creating a protective barrier over the ulcer or sore, thereby reducing pain and facilitating healing. Lidocaine HCl, a local anesthetic, aids in minimizing pain and discomfort. Diphenhydramine HCl, an antihistamine, helps to mitigate inflammation and itching. Lastly, Hydrocortisone, a corticosteroid, is instrumental in reducing inflammation and swelling.
The administration of this formulation should be as per the directions provided by your healthcare provider. It is typically consumed orally, either in the form of a suspension or a tablet. It is crucial to adhere to the instructions on the label meticulously and to consume the medication as prescribed. If you have any queries regarding the administration of this medication, it is advisable to consult with your healthcare provider.
This compounded formulation of Sucralfate 5%/Lidocaine HCl 0.6%/Nystatin 30,000 Units/ml/Diphenhydramine HCl 0.05%/Hydrocortisone 0.05% Compound Oral Suspension is a versatile treatment option for a range of oral conditions. It is a liquid dosage form, where the ingredients are uniformly dispersed throughout a liquid medium, ensuring a homogeneous mixture for administration.
One of the primary uses of this formulation is for the treatment of oral mucositis, a condition that causes inflammation and ulceration of the mouth's mucous membranes.
Additionally, this compound can be used to manage oral lichen planus, a chronic inflammatory condition affecting the mouth's mucous membranes. It is also beneficial for treating oral leukoplakia, characterized by white patches on the mouth's mucous membranes.
Lastly, this formulation can be used to treat oral submucous fibrosis, a condition that leads to the thickening and fibrosis of the mouth's mucous membranes. If you have any questions about using this formulation for any of these conditions, please consult with your healthcare provider.
This is a compounded medication that contains five active ingredients: Sucralfate, Lidocaine HCl, Nystatin, Diphenhydramine HCl, and Hydrocortisone. It is a liquid dosage form where these ingredients are uniformly dispersed throughout a liquid medium, providing a homogeneous mixture for administration.
This compounded formulation is typically used to treat various conditions of the mouth and throat. The combination of these specific medications can help to soothe pain, reduce inflammation, treat fungal infections, and provide a protective coating to the affected area.
This medication is taken orally. The exact dosage and frequency will be determined by your healthcare provider based on your specific condition and response to treatment. Always follow your healthcare provider's instructions.
Side effects can vary depending on the individual and the condition being treated. Common side effects may include dry mouth, constipation, and drowsiness. If you experience any severe or persistent side effects, contact your healthcare provider immediately.
Always consult your healthcare provider before taking any medication if you are pregnant or breastfeeding. They will be able to provide you with the most accurate and up-to-date information based on your specific situation.
It's important to inform your healthcare provider of all medications you are currently taking, including prescription, over-the-counter, vitamins, and herbal supplements. Some medications may interact with this compounded formulation, which could affect how it works or increase your risk for serious side effects.
If you miss a dose, take it as soon as you remember. If it is near the time of the next dose, skip the missed dose and resume your usual dosing schedule. Do not double the dose to catch up.
Store this medication at room temperature, away from light and moisture. Do not store in the bathroom. Keep all medications away from children and pets.
If someone has overdosed and has serious symptoms such as passing out or trouble breathing, call emergency services immediately. Otherwise, call a poison control center right away.
If you have an allergic reaction to this medication, including rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, or trouble breathing, seek medical attention immediately.
This formulation is compounded by Bayview Pharmacy on a prescriber's order for an individual patient. It is not an FDA-approved drug product, and the FDA has not evaluated it for safety, effectiveness, or manufacturing quality.
The conditions listed on this page are indications prescribers have ordered this preparation for. They are not FDA-approved indications, and listing them is not a statement that this preparation is effective for them.
A valid prescription is required. Availability depends on Bayview's licensure in your state. This page is general information, not medical advice — discuss your situation with a licensed healthcare provider.
Search by NCPDP 4106882, or by name and ZIP: Bayview Pharmacy, Warwick, RI 02886. Select it as the destination pharmacy and save it as a favorite. Click any value to copy it.
Compounded preparations have no NDC, so this formula will not appear in your EHR's drug search. Use your system's compound, non-formulary, or free-text prescription entry and name the preparation exactly as written in step 3. If your EHR forces you to pick a listed drug, pick the closest entry for the active ingredient and put the full formula in the prescription body (the Sig or directions field), not in Notes to Pharmacy.
Compounded preparations have no NDC and will not appear in your drug search. For EPCS to validate, select a drug entry your EHR recognizes as controlled, usually the bulk powder entry for the active ingredient (for example Ketamine (bulk) powder, not a branded product), then put the full formula from step 3 in the prescription body. A free-text entry that does not validate as controlled will be rejected by your EPCS module.
Quantity and directions are starting points for this dose form, not treatment recommendations. Dosing remains the prescriber's responsibility.
Transmit from your EHR. For this non-controlled preparation we also accept fax to (401) 284-4506 and phoned orders at (401) 284-4505. Order forms are on the formulation pages and in the prescriber portal.
Transmit with two-factor authentication through your EPCS-enabled EHR. No order form is offered for this preparation; e-prescribing guides for our controlled preparations are on the formulation pages.
Licensed to dispense in RI, MA, CT, NJ, NH, FL, ME, and PA; New York is served on a limited basis while nonresident registration is pending. Compounded preparations are not FDA-approved. A valid prescription is required. Full guide, including steps by EHR: How to e-prescribe to Bayview. Questions about this formula: call (401) 284-4505.
Take orally
